Journal of the American Society for Mass SpectrometryBioinformaticsPeer-reviewed journal article
Automated machine learning and explainable AI (AutoML-XAI) for metabolomics: improving cancer diagnostics
Abstract
MotivationMetabolomics generates complex data necessitating advanced computational methods for generating biological insight. While machine learning (ML) is promising, the challenges of selecting the best algorithms and tuning hyperparameters, particularly for nonexperts, remain. Automated machine learning (AutoML) can streamline this process; however, the issue of interpretability could persist. This research introduces a unified pipeline that combines AutoML with explainable AI (XAI) techniques to optimize metabolomics analysis. ResultsWe tested our approach on two datasets: renal cell carcinoma (RCC) urine metabolomics and ovarian cancer (OC) serum metabolomics. AutoML, using auto-sklearn, surpassed standalone ML algorithms such as SVM and random forest in differentiating between RCC and healthy controls, as well as OC patients and those with other gynecological cancers (Non-OC). Autosklearn employed a mix of algorithms and ensemble techniques, yielding a superior performance (AUC of 0.97 for RCC and 0.85 for OC). Shapley Additive Explanations (SHAP) provided a global ranking of feature importance, identifying dibutylamine and ganglioside GM(d34:1) as the top discriminative metabolites for RCC and OC, respectively. Waterfall plots offered local explanations by illustrating the influence of each metabolite on individual predictions. Dependence plots spotlighted metabolite interactions, such as the connection between hippuric acid and one of its derivatives in RCC, and between GM3(d34:1) and GM3(18:1_16:0) in OC, hinting at potential mechanistic relationships. Through decision plots, a detailed error analysis was conducted, contrasting feature importance for correctly versus incorrectly classified samples. In essence, our pipeline emphasizes the importance of harmonizing AutoML and XAI, facilitating both simplified ML application and improved interpretability in metabolomics data science. Availabilityhttps://github.com/obifarin/automl-xai-metabolomics Contact: facundo.fernandez@chemistry.gatech.edu
- organism: human
- assay: metabolomics
- research focus: benchmarking
- research focus: differential expression
- research focus: cell-cell communication
- research focus: drug response / drug discovery
- approach: machine learning (classical)
- approach: statistical model
- Citations
- 50
- FWCI
- 6.82
- Field percentile
- top 2%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Multi-Omics and AI-/ML-Driven Integration of Nutrition and Metabolism in Cancer: A Systematic Review, Meta-Analysis, and Translational Algorithm
Zafar Iqbal, Lubna Alnuaim, … Giuseppe Nicola Saglio·medRxiv·Jul 29, 2025
- MetaSage: Machine Learning-Based Prioritization of Metabolic Regulators from Multi-Omics Data
Chenwei Wang, John M. Elizarraras, Bing Zhang·bioRxiv·Jul 9, 2025
- Deep learning accurately predicts estrogen receptor status in breast cancer metabolomics data
Fadhl Alakwaa, Kumardeep Chaudhary, Lana Xia Garmire·Journal of Proteome ResearchPeer-reviewed·Nov 7, 2017
- Interpretable machine learning with tree-based Shapley additive explanations: application to metabolomics datasets for binary classification
Olatomiwa O. Bifarin·PLoS ONEPeer-reviewed·May 4, 2023
- Benchmarking feature selection and feature extraction methods to improve the performances of machine-learning algorithms for patient classification using metabolomics biomedical data.
Justine Labory, Evariste Njomgue-Fotso, Silvia Bottini·Computational and Structural Biotechnology JournalPeer-reviewed·Mar 19, 2024
- Unlocking Precision Diagnostics: A Multimodal Framework Integrating Metabolomics with Advanced Machine Learning Techniques
Parisa Shahnazari, Kaveh Kavousi, … Reza M. Salek·PLoS ONEPeer-reviewed·Jun 15, 2026